Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiety: Overview01:18

Anxiety: Overview

1.2K
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.2K
Stress and Mental Health01:30

Stress and Mental Health

1.1K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

872
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
872
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

1.3K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.3K
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

927
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
927
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

69.0K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
69.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico study of the pharmacokinetics and human and environmental toxicological analysis of cannabidiol.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Balancing efficacy and safety: The dual impact of antiseizure medications on the developing brain.

Epilepsy & behavior : E&B·2025
Same author

Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice.

Neurotoxicity research·2024
Same author

Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.

Pharmacology, biochemistry, and behavior·2024
Same author

Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses.

Acta neuropsychiatrica·2022
Same author

Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects.

Neuropharmacology·2021

Related Experiment Video

Updated: Mar 9, 2026

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

5.7K

The Endocannabinoid System and Anxiety.

S F Lisboa1, F V Gomes2, A L B Terzian1

  • 1Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo (USP), Ribeirão Preto, Brazil.

Vitamins and Hormones
|January 8, 2017
PubMed
Summary

The endocannabinoid (eCB) system and cannabinoids influence anxiety, with effects varying by brain region and mechanism. Research explores eCB system modulation for anxiety disorder treatments.

Keywords:
AmygdalaAnimal modelsAnxietyBed nucleus of the stria terminalisEndocannabinoidsHippocampusMedial prefrontal cortexPeriaqueductal gray

More Related Videos

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.3K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

32.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

5.7K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

20.3K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

32.9K

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Medical Cannabis Research

Background:

  • The endocannabinoid (eCB) system, discovered after understanding Cannabis sativa's properties, plays a role in various physiological functions.
  • Cannabinoids and the eCB system can have opposing effects on functions like anxiety, with mechanisms not fully elucidated.
  • Understanding the eCB system's influence on mental health, particularly anxiety disorders, is an active area of research.

Purpose of the Study:

  • To review recent research on the relationship between the endocannabinoid system and anxiety disorders in humans and animal models.
  • To summarize current data on eCB modulation in key brain areas implicated in anxiety.
  • To discuss the mechanisms underlying the eCB system's modulation of anxiety-related behaviors.

Main Methods:

  • Review of recent scientific literature and research findings.
  • Summarization of data from human and animal studies on the eCB system and anxiety.
  • Analysis of mechanisms involving receptors, neurotransmitters, HPA axis, and immune system.

Main Results:

  • The eCB system's modulation in specific brain regions (e.g., medial prefrontal cortex, amygdala) is linked to anxiety.
  • Animal models reveal complex mechanisms, including receptor involvement, neurotransmitter release, HPA axis, and immune responses.
  • Cannabinoids and eCBs can exert differential effects on anxiety-related behaviors.

Conclusions:

  • The endocannabinoid system is a significant target for understanding and potentially treating anxiety disorders.
  • Further research is needed to fully elucidate the complex mechanisms involved in eCB system modulation of anxiety.
  • Targeting specific components of the eCB system may offer novel therapeutic strategies for anxiety.